D46.A
Refractory cytopenia with multilineage dysplasia
Clinical Classification Guidelines
Medical Intelligence & Overview
Refractory cytopenia with multilineage dysplasia (RCMD) is a type of blood disorder characterized by low blood cell counts that do not improve with standard treatments. It is classified under ICD-10 as D46.A. This condition is a subtype of myelodysplastic syndromes, which are a group of disorders caused by poorly formed or dysfunctional blood cells. Patients often experience symptoms related to the deficiency of blood components, and the condition requires careful monitoring and management.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting blood cell production Exposure to radiation or certain chemotherapy drugs Environmental toxins Inherited genetic factors Idiopathic origins, where no specific cause is identified
Key Symptoms: Fatigue and weakness Increased risk of infections due to low white blood cell counts Easy bruising or bleeding resulting from low platelet counts Pale skin caused by anemia Shortness of breath on exertion Fever or night sweats in some cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves blood tests showing cytopenia (reduction in blood cells), as well as bone marrow biopsies revealing multilineage dysplasia. Additional tests may include genetic analysis to identify mutations associated with the disorder. The diagnosis process aims to rule out other causes of blood cell abnormalities and confirm the presence of dysplastic changes across multiple blood cell lineages.
Treatment Protocols: Management of RCMD focuses on alleviating symptoms and preventing complications. Treatment options may include blood transfusions to address anemia, growth factors to stimulate blood cell production, and medications to manage infections or bleeding risks. In some cases, more intensive therapies such as chemotherapy or stem cell transplantation might be necessary, especially if the disease progresses or transforms into acute leukemia. Regular monitoring is essential to assess disease progression and adjust treatment strategies accordingly.
Clinical Advice & FAQs
Billing Guidance
Is D46.A a billable ICD-10 code?
Yes, D46.A is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D46.A?
Clinical documentation must specify the nature of Refractory cytopenia with multilineage dysplasia and any associated comorbidities for accurate reporting.
Cite this Clinical Reference